These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27646566)

  • 1. Exploring Differences between TTO and DCE in the Valuation of Health States.
    Robinson A; Spencer AE; Pinto-Prades JL; Covey JA
    Med Decis Making; 2017 Apr; 37(3):273-284. PubMed ID: 27646566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
    Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
    Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks.
    Che M; Pullenayegum E
    Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
    Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
    Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
    Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
    Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
    Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
    Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China.
    Xie S; Wu J; He X; Chen G; Brazier JE
    Value Health; 2020 Oct; 23(10):1391-1399. PubMed ID: 33032784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?
    Augestad LA; Rand K; Luo N; Barra M
    Value Health; 2020 Apr; 23(4):487-494. PubMed ID: 32327166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a discrete choice experiment to estimate health state utility values.
    Bansback N; Brazier J; Tsuchiya A; Anis A
    J Health Econ; 2012 Jan; 31(1):306-18. PubMed ID: 22197308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.
    Norman R; Cronin P; Viney R
    Appl Health Econ Health Policy; 2013 Jun; 11(3):287-98. PubMed ID: 23649892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
    Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
    Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs).
    Yiu HHE; Buckell J; Petrou S; Stewart-Brown S; Madan J
    Soc Sci Med; 2023 Jun; 327():115928. PubMed ID: 37201343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Both Time Tradeoff and Discrete Choice Experiments in Valuing the EQ-5D: Impact of Model Misspecification on Value Sets.
    Waudby-Smith I; Pickard AS; Xie F; Pullenayegum EM
    Med Decis Making; 2020 May; 40(4):483-497. PubMed ID: 32517541
    [No Abstract]   [Full Text] [Related]  

  • 17. A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.
    Robinson A; Spencer A; Moffatt P
    Med Decis Making; 2015 Apr; 35(3):341-50. PubMed ID: 25349189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Class Models Reveal Poor Agreement between Discrete-Choice and Time Tradeoff Preferences.
    Pullenayegum EM; Pickard AS; Xie F
    Med Decis Making; 2019 May; 39(4):421-436. PubMed ID: 30982403
    [No Abstract]   [Full Text] [Related]  

  • 19. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
    Ramos-Goñi JM; Craig BM; Oppe M; Ramallo-Fariña Y; Pinto-Prades JL; Luo N; Rivero-Arias O
    Value Health; 2018 May; 21(5):596-604. PubMed ID: 29753358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New methods for modelling EQ-5D-5L value sets: An application to English data.
    Feng Y; Devlin NJ; Shah KK; Mulhern B; van Hout B
    Health Econ; 2018 Jan; 27(1):23-38. PubMed ID: 28833854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.